Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Johnson & Johnson is one of the world’s largest healthcare companies, with major businesses in pharmaceuticals and medical technology. Founded in 1886, the company has long been a giant in global healthcare, but its current structure looks different from older versions of the business.
The most important change for a 2026 update is that Johnson & Johnson is no longer reporting a consumer health segment inside the company after completing the separation of Kenvue in 2023. That means the most useful current J&J statistics now focus on Innovative Medicine, MedTech, total company sales, earnings and employees.
Johnson & Johnson Quick Answer
Johnson & Johnson reported $88.8 billion in 2024 sales, earned $14.1 billion in net earnings, and employed approximately 138,100 people. The company now reports its business in two main segments: Innovative Medicine and MedTech.
Johnson & Johnson Key Metrics
| Metric | Latest figure | Year |
|---|---|---|
| Total sales | $88.8 billion | 2024 |
| Net earnings | $14.1 billion | 2024 |
| Employees | 138,100 | 2024 |
| Innovative Medicine sales | $57.0 billion | 2024 |
| MedTech sales | $31.9 billion | 2024 |
About Johnson & Johnson
Johnson & Johnson today is a healthcare company centered on pharmaceuticals and medical technology. That is a meaningful change from older company profiles that emphasized consumer brands like Band-Aid, Tylenol and Neutrogena inside the parent company.
Those brands are now part of Kenvue, so a current J&J statistics page should not present consumer health as an ongoing core segment of Johnson & Johnson itself.
Johnson & Johnson Revenue Statistics
Johnson & Johnson generated $88.8 billion in 2024 sales, up from $85.2 billion in 2023.
| Year | Revenue / sales |
|---|---|
| 2024 | $88.8 billion |
| 2023 | $85.2 billion |
| 2022 | $80.0 billion |
| 2021 | $93.8 billion |
| 2020 | $82.6 billion |
| 2019 | $82.1 billion |
| 2018 | $81.6 billion |
Johnson & Johnson Net Earnings Statistics
Net earnings for 2024 were $14.1 billion, up from $13.3 billion in 2023.
| Year | Net earnings |
|---|---|
| 2024 | $14.1 billion |
| 2023 | $13.3 billion |
| 2022 | $17.9 billion |
| 2021 | $20.9 billion |
| 2020 | $14.7 billion |
| 2019 | $15.1 billion |
| 2018 | $15.3 billion |
Segment Statistics
In 2024, Johnson & Johnson reported $56.964 billion in Innovative Medicine sales and $31.857 billion in MedTech sales.
That segment mix reflects the company’s current operating structure after Kenvue.
Johnson & Johnson Employee Statistics
Johnson & Johnson had approximately 138,100 employees in 2024.
FAQ
How much revenue does Johnson & Johnson make?
Johnson & Johnson reported $88.8 billion in 2024 sales.
How many employees does Johnson & Johnson have?
The company had approximately 138,100 employees in 2024.
What are Johnson & Johnson’s current business segments?
Johnson & Johnson currently reports two major segments: Innovative Medicine and MedTech.
Does Johnson & Johnson still own Band-Aid and Tylenol?
Those consumer brands moved to Kenvue after the separation completed in 2023, so they are no longer part of Johnson & Johnson’s ongoing operating structure.
Sources / References
